ArticleFrontiers in pharmacology2025

Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network.

Antonio Vitale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.